Trails Edge Capital Partners, LP: IMMUNOCORE HLDGS PLC (IMCR): Quarterly 13F Position History
As of Q2 2026, Trails Edge Capital Partners, LP reported 1,063,234 shares of IMMUNOCORE HLDGS PLC (IMCR), worth $33.8M and representing 5.4% of its 13F equity book. Quarter-over-quarter share count change: + 380,637 (+55.8%) . The position first appeared in Q4 2025 and has been disclosed across 3 13F-HR filings in Pactolio's tracked window.
- 1,063,234Shares Held (Latest Filing)
- $33.8MReported Market Value (Latest Filing)
- 5.4%Portfolio Weight (% of 13F Equity Book)
- +380,637Quarter-over-Quarter Share Change
- +$13.2MQuarter-over-Quarter Value Change
- 1,063,234Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 3 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,063,234 | +380,637 | +55.8% | $33.8M | 5.4% | $31.8 |
| Q1 2026 | 682,597 | 0 | – | $20.6M | 4.8% | $30.1 |
| Q4 2025 | 682,597 | – | – | $23.7M | 5.9% | $34.7 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did Trails Edge Capital Partners, LP first disclose a IMCR position in 13F-HR filings?
Trails Edge Capital Partners, LP first reported IMMUNOCORE HLDGS PLC (IMCR) on its 13F-HR filing for the period ending 2025-12-31 (Q4 2025). The position has appeared on 3 reported quarters within Pactolio's tracked window.
What was Trails Edge Capital Partners, LP's most recent quarter-over-quarter share-count change in IMCR?
Between Q1 2026 and Q2 2026, Trails Edge Capital Partners, LP added 380,637 shares of IMCR (+55.8%), bringing the total reported position to 1,063,234 shares at a market value of $33.8M.
Does the implied price-per-share represent Trails Edge Capital Partners, LP's cost basis in IMCR?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.